Bayer To Stop Selling Essure After Dec. 31, Will Continue FDA-Required Postmarket Study

Bayer will stop selling and distributing its permanent birth control device Essure after Dec. 31 citing commercial reasons, FDA announced Friday (July 20), coming three months after the agency limited Essure to prescription-only in the face of years of adverse events and congressional pressure to step up its oversight. According to Bayer's Quarter 1 financial report, as of April, 16,800 lawsuits have been filed against Bayer by Essure users. The company anticipates additional lawsuits, it writes. The decision to stop...